Leber Congenital Amaurosis 5-Like (LCA5L) Peptide
LCA5L
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits LCA5L
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Type de proteíne
- Synthetic
- Origine
- Mammifères
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- GSEEPLQSKE SHPLPPSQAS TSHAFGDSKV TVVNSIKPSS PTEGKRKIII
- Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of C21 orf13 antibody,
Alternative Names: C21ORF13 control peptide, C21ORF13 antibody Blocking Peptide, Anti-C21ORF13 Blocking Peptide, MGC33295 Blocking Peptide
-
-
- Indications d'application
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C long term.
-
- Antigène
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Synonymes
- C21orf13 Peptide, 4921526F01Rik Peptide, Lcca5l Peptide, Leber congenital amaurosis 5-like Peptide, LCA5L, lebercilin like Peptide, LCA5L Peptide, Lca5l Peptide
- Sujet
- The function of the C21orf13 protein has not been widely studied, and is yet to be fully elucidated.
- Poids moléculaire
- 76 kDa
-
Vous êtes ici:
